NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 11 04:00PM ET
7.50
Dollar change
-0.02
Percentage change
-0.27
%
Index- P/E- EPS (ttm)-1.10 Insider Own1.82% Shs Outstand5.04M Perf Week0.94%
Market Cap37.80M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float4.95M Perf Month-7.06%
Enterprise Value130.54M PEG- EPS next Q- Inst Own0.82% Short Float0.14% Perf Quarter11.28%
Income-9.51M P/S0.02 EPS this Y- Inst Trans-34.35% Short Ratio0.60 Perf Half Y31.58%
Sales2.00B P/B- EPS next Y- ROA-2.49% Short Interest0.01M Perf YTD20.39%
Book/sh-17.94 P/C0.49 EPS next 5Y- ROE- 52W High12.90 -41.86% Perf Year-26.47%
Cash/sh15.24 P/FCF- EPS past 3/5Y56.27% 34.73% ROIC- 52W Low4.14 80.94% Perf 3Y-64.95%
Dividend Est.- EV/EBITDA- Sales past 3/5Y1.27% 28.46% Gross Margin5.66% Volatility3.67% 5.94% Perf 5Y-88.77%
Dividend TTM- EV/Sales0.07 EPS Y/Y TTM82.04% Oper. Margin-0.06% ATR (14)0.43 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.53 Sales Y/Y TTM-3.15% Profit Margin-0.48% RSI (14)46.87 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.14 EPS Q/Q-25.20% SMA20-1.59% Beta0.44 Target Price57.01
Payout- Debt/Eq- Sales Q/Q-1.19% SMA50-4.51% Rel Volume0.13 Prev Close7.52
Employees1238 LT Debt/Eq- EarningsJun 19 BMO SMA200-1.73% Avg Volume11.37K Price7.50
IPOSep 12, 2018 Option/ShortNo / Yes EPS/Sales Surpr.- -7.48% Trades Volume1,592 Change-0.27%
Date Action Analyst Rating Change Price Target Change
Apr-15-21Resumed Citigroup Buy $16
Jun-19-25 03:03AM
Apr-21-25 04:29PM
Mar-20-25 03:03PM
01:00AM
Mar-12-25 07:00AM
05:00AM Loading…
Feb-20-25 05:00AM
Feb-11-25 08:00AM
Jan-08-25 05:00AM
Nov-28-24 06:33AM
02:01AM
Nov-27-24 05:02AM
01:00AM
Nov-21-24 05:00AM
Nov-04-24 06:00AM
05:00AM
05:10AM Loading…
Oct-22-24 05:10AM
Oct-18-24 05:00AM
Oct-10-24 06:02AM
Sep-27-24 05:00PM
Sep-13-24 07:30AM
Aug-29-24 02:00AM
Aug-27-24 08:00AM
Jul-29-24 01:00AM
Jul-19-24 08:45AM
Jul-17-24 01:31AM
Jun-11-24 03:57AM
May-23-24 08:52AM
04:43AM
Apr-30-24 02:30AM
Mar-22-24 11:36AM
04:47AM Loading…
Mar-21-24 04:47AM
Mar-01-24 04:00AM
Feb-27-24 08:58AM
Dec-01-23 09:20AM
Nov-30-23 01:00AM
Nov-13-23 12:10AM
Aug-31-23 08:09AM
Aug-24-23 02:00AM
Jul-31-23 05:59AM
Jun-15-23 05:03AM
01:15AM
May-25-23 02:05AM
Mar-27-23 06:26AM
Mar-23-23 05:07AM
02:17AM
Mar-02-23 02:35AM
Feb-16-23 12:33AM
Dec-01-22 02:33AM
Nov-08-22 01:09AM
Sep-23-22 12:30AM
Sep-09-22 05:53AM
Aug-25-22 02:18AM
Aug-08-22 01:19PM
Aug-05-22 02:26AM
Jun-16-22 03:58AM
May-26-22 04:59AM
May-05-22 01:46PM
05:18AM
Apr-13-22 05:02AM
Mar-17-22 03:20AM
Mar-14-22 07:35AM
Mar-04-22 04:24AM
Mar-01-22 08:55AM
Feb-22-22 03:38AM
Jan-03-22 09:38PM
Nov-22-21 12:14PM
Nov-19-21 12:31AM
Nov-01-21 04:57PM
Oct-28-21 07:00PM
Oct-25-21 07:00AM
Sep-17-21 07:00AM
Sep-07-21 05:00AM
Aug-27-21 02:30AM
Aug-16-21 08:00AM
Aug-13-21 07:16AM
Aug-09-21 07:30AM
Aug-03-21 08:00AM
Jun-18-21 10:09AM
May-19-21 02:17AM
May-12-21 10:10AM
Apr-21-21 08:00AM
Mar-25-21 05:00AM
Mar-18-21 06:10AM
Mar-17-21 06:50AM
Mar-16-21 05:40AM
Feb-05-21 06:00AM
Jan-01-21 03:24AM
Dec-22-20 04:22AM
Nov-29-20 11:42AM
Nov-19-20 05:00AM
Oct-22-20 06:00AM
Oct-19-20 06:50AM
Oct-15-20 05:40PM
05:35PM
05:30PM
Sep-30-20 06:00AM
Sep-23-20 12:53PM
Sep-04-20 06:22AM
Aug-20-20 04:35AM
04:30AM
111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.